How Has The Serum Institute Ramped Up Export Of Covishield?

  • 1:53
  • Published On: November 30, 2021
Cinema View
Embed
"We have hundred of millions of stock in our campus. We have over 200 million doses reserved for states and UTs in India. So, if the government is to announce a booster dose, we are well stocked," says Serum Institute of India's chief executive Adar Poonawalla.

Related Videos

AstraZeneca Initiates A Global Withdrawal Of Its Covid-19 Vaccine
May 08, 2024 2:12
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
May 08, 2024 2:54
AstraZeneca Withdraws Covid Vaccine, Cites Commercial Reasons: Report
May 08, 2024 0:45
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
May 06, 2024 1:53
"Doctors Were Clueless, Didn't Suspect Vaccine": Man Whose Daughter Died Due To Vaccine Side-Effect
May 05, 2024 4:27
"All Drugs, Vaccines Come With Some Side-Effects": Top Expert
May 05, 2024 1:07
"No Vaccine Is 100% Effective Or 100% Safe": Expert On Covishield Concern
May 05, 2024 2:18
AstraZeneca Covid 19 Vaccine Side Effects | What Is TTS, A Rare Condition Caused By Covishield
May 01, 2024 4:03
Astrazeneca's Big U-Turn, Admits Rare Blood Clot Risk
April 30, 2024 2:21
AstraZeneca Makes Big U-Turn, Admits Covishield Can Cause Rare Side Effects
April 30, 2024 2:48
Adar Poonawalla To Buy London's Most Expensive House: Reports
December 12, 2023 0:41
Current Covid Strain Mild, 5-6 Million Covovax Doses Made: Adar Poonawalla
April 22, 2023 1:07
Our Offerings: NDTV
  • मध्य प्रदेश
  • राजस्थान
  • इंडिया
  • मराठी
  • 24X7
Choose Your Destination